Charles RC, Bruce RK, Laura KS. Formulation of acetylsalicylic acid tablets for aqueous enteric film coating. Pharm Tech Drug Del 2001; 13(5): 44-53.
Kambiz Y. Dry powder inhaler and methods of use. US9757529 (2019).
Kambiz Y. Dry powder aspirin compositions with magnesium stearate. US10195147 (2019).
Kumud KP, Nilamkumari SP, Sunil CK, Amit M, Indravadan AM, Rajiv IM. Stable pharmaceutical composition for atherosclerosis. CN102480954 (2015).
Somberg JC, Ranade VV. Formulation of aspirin that is stable and showing minimal hydrolysis for parenteral adminstration for the treatment of cardiovascular and other disease states.US20100173875 (2010).
Manoj S, James B, Robert S. Enteric coated aspirin granules comingled with binder. US8057820 (2011)
Bilgiç M. Pharmaceutical formulations containing atorvastatin and aspirin. TR201005325 (2010).
Humera A, Jing L, Ram G. Aspirin soft gelatin capsule as a single active or in combination with other actives. WO2017095736 (2017).
Jaiswal S, Krishna S, Shirish K. Compact solid dosage form of aspirin and clopidogrel. WO2017037741 (2017).
Brenne JF, Frédérique C, Georges D, Edeline-berlemont J, Fontaine N. Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel. WO2015014766 (2015).
Fumitoshi A, Atsuhiro S, Taketoshi O, Teruhiko I. Method of treatment with coadministration of aspirin and prasugrel.US8569325 (2013).
Kelly JP. Use of caffeine and aspirin in synergistic amounts for improving performance. WO2011117322 (2012).
Jacob JN. Formulations from natural products, turmeric, and aspirin.CA2786255 (2011).
Shanta D, Rakesh P. Prodrug for release of cisplatin and cyclooxygenase inhibitor. WO2015089389 (2015).
Eradel MS, Gungor S, Ozsoy Y, Araman A. Preparation and in vitro evaluation of indomethacin loaded solid lipid microparticles. Acta Pharmaceiutical Sciencia 2009; 51: 203-10.
Richard J, Fais F, Baldascini H. Solid lipid microcapsules containing hGH. WO2010017965 (2010).
Kaur IP, Verma MK. Process for preparing solid lipid sustained release nanoparticles for delivery of vitamins. US9907758 (2018).
Kaur IP, Bhandari R. Solid lipid nanoparticles entrapping hydrophilic/amphiphilic drug and process for preparing the same.WO2013105101 (2014).
Zhou Y, Wang N, Wang T. Novel preparation method of solid lipid nanoparticles. CN201010112202 (2010).
Sobrinho Soares JL, Melo Tiburcio CDCS, De Freitas FHRDRMDLS, Oliveira De Lacerda NPCD. Production of lipid nanoparticles by microwave synthesis. WO2018109690 (2018).
Burke P, Gindy M, Mathre D. Preparation of lipid nanoparticles.WO2011127255 (2011).
Repka MA, Patil HG, Majumdar S, Park JB, Kulkarni VI. Systems and methods for preparing solid lipid nanoparticles.WO2015148483 (2015).
Weiss J, Schweiggert C, Leuenberger B, Novotny M, Tedeschi C, Kessler A. Solid lipid nanoparticles (I). US9616001 (2017).
Sun JH, Yuan H, Liu F, Chen SQ. Solid lipid magnetic resonance nanoparticles and preparation method and use thereof.WO2017041609 (2017).
Munhoz A, De Vecchi R, Eduardo Durán Caballero N, Xavier Pinto Dini A, De Jesus MB. Nanostructured lipid carriers and methods for making and using them. WO2017185155 (2017).
Mosqueira CF, Oliveira LT, Castanheira RG. Micro- and nanostructured pharmaceutical and veterinary compositions, containing benznidazole and derivatives thereof, which form micro and nanostructures in the gastrointestinal tract, and biologicals uses thereof. WO2015039199 (2015).
Bara I. Composition of Pickering emulsion type based on hydrophobic silica particles. WO2013076673 (2013).
Lauriane A, Studart A, Tervoort E, Leuenberger B, Teleki A, Mesaros S. Pickering emulsions. WO2016124522 (2016).
Karasulu HY, Apaydin S, Gundogdu E, et al. Selfmicro/nanoemulsifying drug carrying system for oral use of rosuvastatin.WO2015142307 (2015).
Premchand N, Prashant M, Girish KG, Munish T. Selfemulsifying pharmaceutical compositions of rhein or diacerein.US8999381 (2015).
Shabaik Y, Jiao J, Pujara CP. Self-Emulsifying Drug Delivery System (SEDDS) for ophthalmic drug delivery. WO2016141098 (2016).
Khan MA, Nazzal S. Eutectic-based self-nanoemulsified drug delivery system. US8790723 (2014).
Bansal AK, Munjal B, Patel SB. Self-nano-emulsifying curcuminoids composition with enhanced bioavailability. WO2010010431 (2010).,
Garti N, Aserin A, Libster D, Mishraki T, Amar-Yuli I, Bitan-Chervkovsky L. Reverse hexagonal mesophases (hii) and uses thereof. WO2010150262 (2011).
Dahl-Kyun OH, Kyun-Young L. Preparation of nanoliposomeencapsulating proteins and protein-encapsulated nanoliposome.US7951396 (2011).
Fatmi A, Kim TKE. Methods for enhancing the release and absorption of water insoluble active agents. WO2010075065 (2010).
Wu N, Keller BC. Lipid drug conjugates for drug delivery. WO2010107487 (2010).
Pratibha SP, Maharukh TR, Anilkumar SG. Sustained release compositions of anti-alzheimer's agents. WO2012035409 (2012).
Yerramilli VSN. Phospholipid gel compositions for drug delivery and methods of treating conditions using same. US7846472 (2010).
Satyavani K, Ramanathan T, Gurudeeban S, Balasubramanian T. Drug for treatment of diabetes and diabetic foot ulcer using rutin loaded solid lipid nanoparticles. IN718/CHE/2013 (2013).
Kumar SS, Mohanty C. A novel water soluble curcumin loaded nanoparticulate system for cancer therapy. WO2011101859 (2011).,
Sally AF, Gregory MC. Bioavailable curcuminoid formulations for treating Alzheimer's disease and other age-related disorders.US20090324703 (2009).
Vassal GP, Ioulalen K, Brun BC, Lassu N. Galenic form under the form of solid lipid particles, useful in pediatrics, comprise temozolomide in lipid matrix, where the matrix comprises triglycerides with saturated fatty acids, and a mixture of fatty acids with specific fatty acids. FR2935270 (2010).
Umeyor CE, Kenechukwu FC, Uronnachi EM, Osonwa UE, Nwakile CD. Solid Lipid Microparticles (SLMs): An effective lipid based technology for controlled drug delivery. Am J Pharm Tech Res 2012; 2(6): 1-18.
Viladot Petit JL. Lipid nanoparticles capsules. WO2011116963 (2011).
Benoit JP, Ferrier T. Method for preparing functionalized lipid capsules. WO2010113111 (2010).
Galuska PE, Rasmussen LM. Processes for producing lipid particles.US2010233344 (2010).
Onyishi IV, Chime SA, Okoroji CA. Physicochemical properties of microcrystalline cellulose from Saccharum officinarum: Comparative evaluation with Avicel® pH 101. Am J Pharm Tech Res 2013; 3(5): 414-26.
Aulton ME. Pharmaceutics; The Science of Dosage Form Design. 1st ed. Edinburgh: Churchill Living Stone 1999.
Aulton ME. Pharmaceutics; The Science of Dosage Form Design. 3rd ed. Edinburgh: Churchill Living Stone 2007; pp. 197-210.
Kenechukwu FC, Attama AA, Ibezim EC, Nnamani PO. Umeyor CE, Uronnachi EM, et al.Novel intravaginal drug delivery system based on molecularly pegylated lipid matrices for improved antifungal activity of miconazole nitrate. BioMed Res Int 2019; 2018 3714329.
Uronnachi EM, Ogbonna JDN, Kenechukwu FC, Attama AA, Chime SA. Properties of zidovudine loaded solidified reverse micellar microparticles prepared by melt dispersion. J Pharm Res 2012; 5(5): 2870-4.
Kalam MA, Humayun M, Parvez N, Yadav S, Garg A, Amin S, et al. Release kinetics of modified pharmaceutical dosage forms: A review. Continental J Pharm Sci 2007; 1: 30-5.
Chime SA, Onunkwo GC, Onyishi IV. Kinetics and mechanisms of drug release from swellable and non swellable matrices: A review. Res J Pharm Biol Chem Sci 2013; 4(2): 97-103.
Anosike AC, Onyechi O, Ezeanyika LUS, Nwuba MM. Anti-inflammatory and anti-ulcerogenic activity of the ethanol extract of ginger (Zingiber officinale). Afr J Biochem Res 2009; 3(12): 379-84.
Momoh MA, Akpa PA, Attama AA. Phospholipon 90G based SLMs loaded with ibuprofen: An oral anti-inflammatory and gastrointestinal sparing evaluation in rats. Pak J Zool 2013; 44(6): 1657-64.